Because less of the drug enters the bloodstream, they avoid most of the stomach and kidney risks of oral NSAIDs
Jay Shubrook, professor of the Primary Care Department at Touro University, California, noted that all GLP-1 drugs, as pharmacological agents, can have side effects
Millions of people with Medicare and Medicaid could benefit from expanded coverage of GLP-1s for obesity Overall, CMSs efforts to expand Medicare and Medicaid coverage of GLP-1s for people with Medicare and Medicaid could greatly expand access to these drugs, albeit on a temporary basis, depending on the level of participation by drug manufacturers, state Medicaid agencies and Part D plans
Enhances fat burning during exercise
FEMS Yeast Research, 2(3), 295305